Singh M - Search Results

1

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

Wack A, Baudner BC, Hilbert AK, Manini I, Nuti S, Tavarini S, Scheffczik H, Ugozzoli M, Singh M, Kazzaz J, Montomoli E, Del Giudice G, Rappuoli R, O'Hagan DT. Wack A, et al. Among authors: singh m. Vaccine. 2008 Jan 24;26(4):552-61. doi: 10.1016/j.vaccine.2007.11.054. Epub 2007 Dec 7. Vaccine. 2008. PMID: 18162266

2

Cationic microparticles are a potent delivery system for a HCV DNA vaccine.

O'Hagan DT, Singh M, Dong C, Ugozzoli M, Berger K, Glazer E, Selby M, Wininger M, Ng P, Crawford K, Paliard X, Coates S, Houghton M. O'Hagan DT, et al. Among authors: singh m. Vaccine. 2004 Dec 16;23(5):672-80. doi: 10.1016/j.vaccine.2004.06.037. Vaccine. 2004. PMID: 15542189

3

A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens.

Singh M, Ugozzoli M, Kazzaz J, Chesko J, Soenawan E, Mannucci D, Titta F, Contorni M, Volpini G, Del Guidice G, O'Hagan DT. Singh M, et al. Vaccine. 2006 Mar 6;24(10):1680-6. doi: 10.1016/j.vaccine.2005.09.046. Epub 2005 Oct 6. Vaccine. 2006. PMID: 16300864

4

MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020).

Baudner BC, Ronconi V, Casini D, Tortoli M, Kazzaz J, Singh M, Hawkins LD, Wack A, O'Hagan DT. Baudner BC, et al. Among authors: singh m. Pharm Res. 2009 Jun;26(6):1477-85. doi: 10.1007/s11095-009-9859-5. Epub 2009 Mar 3. Pharm Res. 2009. PMID: 19255727

5

An alternative renewable source of squalene for use in emulsion adjuvants.

Brito LA, Chan M, Baudner B, Gallorini S, Santos G, O'Hagan DT, Singh M. Brito LA, et al. Among authors: singh m. Vaccine. 2011 Aug 26;29(37):6262-8. doi: 10.1016/j.vaccine.2011.06.067. Epub 2011 Jun 30. Vaccine. 2011. PMID: 21723355

6

The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.

Jain S, O'Hagan DT, Singh M. Jain S, et al. Among authors: singh m. Expert Rev Vaccines. 2011 Dec;10(12):1731-42. doi: 10.1586/erv.11.126. Expert Rev Vaccines. 2011. PMID: 22085176 Review.

7

MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine.

Singh M, Kazzaz J, Ugozzoli M, Baudner B, Pizza M, Giuliani M, Hawkins LD, Otten G, O'Hagan DT. Singh M, et al. Hum Vaccin Immunother. 2012 Apr;8(4):486-90. doi: 10.4161/hv.19229. Hum Vaccin Immunother. 2012. PMID: 22832252

8

Recent advances in vaccine adjuvants.

Singh M, O'Hagan DT. Singh M, et al. Pharm Res. 2002 Jun;19(6):715-28. doi: 10.1023/a:1016104910582. Pharm Res. 2002. PMID: 12134940 Review.

9

Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticles.

Otten G, Schaefer M, Greer C, Calderon-Cacia M, Coit D, Kazzaz J, Medina-Selby A, Selby M, Singh M, Ugozzoli M, zur Megede J, Barnett SW, O'Hagan D, Donnelly J, Ulmer J. Otten G, et al. Among authors: singh m. J Virol. 2003 May;77(10):6087-92. doi: 10.1128/jvi.77.10.6087-6092.2003. J Virol. 2003. PMID: 12719603 Free PMC article.

10

Recent advances in veterinary vaccine adjuvants.

Singh M, O'Hagan DT. Singh M, et al. Int J Parasitol. 2003 May;33(5-6):469-78. doi: 10.1016/s0020-7519(03)00053-5. Int J Parasitol. 2003. PMID: 12782048 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,162 results

Search Page

Filters